As a result, GLP-1 medications are FDA-approved specifically for chronic weight management, and are recommended by major medical organizations as part of a comprehensive weight loss program
The results showed that ACV consumption, no matter the dose, led to great reductions in body weight, BMI, waist and hip measurements, and body fat percentage
Your submission has been received
The recent direct-to-consumer/out-of-pocket strategies introduced by companies as lower cost options for their obesity medications, as well as more stringent payor/insurance coverage dynamics, could present some risk of even greater price erosion over the longer-term
Mounjaro also sees substantial price differences, costing around $444 in the Netherlands and $319 in Japan, versus $1,023 in the US